A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease, Anemia
Therapuetic Areas:Hematology, Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:3/9/2017
Start Date:June 30, 2010
End Date:March 7, 2016

Use our guide to learn which trials are right for you!

A Phase 2a, Multi-center, Randomized, Single Dose, Double-blind, Placebo-controlled Followed by a Multiple-dose, Single-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, Efficacy, Tolerability, and Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease (ESRD) on Hemodialysis (HD).

This is the first study in hemodialysis subjects with anemia to evaluate the
pharmacokinetics, safety, efficacy, tolerability, and pharmacodynamics of sotatercept
(ACE-011)

Part 1:

Approximately 8 subjects will be randomized to receive either a single 0.1 mg/kg
subcutaneous dose of sotatercept or matching placebo in a 3:1 ratio

Part 2:

Approximately 8 subjects will be randomized to each of the 3 sequential dose groups
(0.3mg/kg or 0.5mg/kg or 0.7 mg/kg) with a 3:1 ratio of sotatercept or placebo (6 subjects
in the sotatercept arm and 2 in the placebo arm). A total of 24-36 subjects may be
randomized in the 3 dose groups.

Inclusion Criteria:

- Males or females ≥18 years of age.

- Subjects on hemodialysis for at least 12 weeks before screening

- Subjects on a stable dose of Erythrocyte Stimulating Agents product to maintain
Hemoglobin (Hb) for at least 6 weeks prior to screening.

- 3 consecutive pre-dialysis Hb concentrations with a mean ≥10 to ≤ 12 g/dL (≥100 to
≤120 g/L) at screening and one pre-dialysis Hb concentration ≥8 to < 10 g/dL (≥ 80 to
< 100 g/L) before randomization.

- Adequate iron status defined as serum transferrin saturation ≥ 20% before
randomization.

Exclusion Criteria:

- Non renal causes of anemia.

- Subjects on peritoneal dialysis.

- Systemic hematological disease

- High sensitivity C-reactive protein >50mg/L at screening.

- Alanine transaminase (ALT) or aspartate transaminase (AST) laboratory values > 2
times the upper limit of normal (ULN) at screening.

- Uncontrolled diabetes mellitus (HbA1c > 9) at screening.

- Uncontrolled hypertension.

- Red Blood Count (RBC) transfusions within 8 weeks prior to screening.

- Active serious infection or history of recurrent serious infection likely to recur
during the study

- History of severe allergic or anaphylactic reactions or hypersensitivity to
recombinant proteins or excipients in the investigational product or to the iron
products needed to normalize iron levels for subjects.

- Subjects that received treatment with another investigational drug or device within
28 days prior to Day 1

- Pregnant or lactating females.
We found this trial at
24
sites
825 South 8th Street
Minneapolis, Minnesota 55404
888-345-2567
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pembroke Pines, Florida 33028
?
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Azusa, California 91773
?
mi
from
Azusa, CA
Click here to add this to my saved trials
Bethlehem, Pennsylvania 18017
?
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Charlottesville, Virginia 22908
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Cleveland, Ohio 44109
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Glendale, California 91205
?
mi
from
Glendale, CA
Click here to add this to my saved trials
Houston, Texas 77003
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas 77036
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas 77055
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas 77074
?
mi
from
Houston, TX
Click here to add this to my saved trials
Kalamazoo, Michigan 49007
?
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
La Mesa, California 91942
?
mi
from
La Mesa, CA
Click here to add this to my saved trials
Las Vegas, Nevada 89106
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Lexington, Kentucky
859) 257-9000
University of Kentucky The University of Kentucky is a public, land grant university dedicated to...
?
mi
from
Lexington, KY
Click here to add this to my saved trials
Los Angeles, California 90022
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Los Angeles, California 90022
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Nashville, Tennessee 37205
?
mi
from
Nashville, TN
Click here to add this to my saved trials
Orange, California 92868
?
mi
from
Orange, CA
Click here to add this to my saved trials
St. Louis, Missouri 63110
?
mi
from
St. Louis, MO
Click here to add this to my saved trials
St. Louis, Missouri 63108
?
mi
from
St. Louis, MO
Click here to add this to my saved trials
?
mi
from
Tupelo, MS
Click here to add this to my saved trials
Tyler, Texas 75702
?
mi
from
Tyler, TX
Click here to add this to my saved trials
Winston-Salem, North Carolina 27103
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials